Know Cancer

or
forgot password

A Phase I, Pharmacokinetic Study to Evaluate the Extent of Systemic Absorption of PEP005, When Applied as 0.05% PEP005 Topical Gel to a 100 cm2 (5 cm x 20 cm) Contiguous Actinic Keratosis(AK) Treatment Area on the Extensor (Dorsal Aspect) Forearm.


Phase 1
18 Years
N/A
Not Enrolling
Male
Actinic Keratoses

Thank you

Trial Information

A Phase I, Pharmacokinetic Study to Evaluate the Extent of Systemic Absorption of PEP005, When Applied as 0.05% PEP005 Topical Gel to a 100 cm2 (5 cm x 20 cm) Contiguous Actinic Keratosis(AK) Treatment Area on the Extensor (Dorsal Aspect) Forearm.


Actinic keratoses (AK) is a common skin condition characterized by rough, scaly patches or
sores on the top layer of the skin which if left untreated can progress to skin cancer.
Current treatments can cause scarring and hypopigmentation, be inconvenient, or require long
treatment duration. Non-invasive alternative therapy for treatment of AK lesions is thus
being researched.


Inclusion Criteria:



1. Male patients at least 18 years of age.

2. A contiguous 100 cm2 treatment area containing at least 5 AK lesions, on the either
the right or left extensor (dorsal aspect) forearm.

3. Written informed consent has been obtained.

4. Agreement from the patient to allow photographs of the selected AK treatment area to
be taken and used as part of the study package.

Type of Study:

Interventional

Study Design:

Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

To evaluate the extent of systemic absorption of PEP005 when applied as 0.05% Topical Gel on two consecutive days (Day 1 and Day 2) to a 100 cm2 (5 cm x 20 cm) contiguous AK treatment area on the extensor (dorsal aspect) forearm.

Principal Investigator

Janelle Katsamas

Investigator Role:

Study Director

Investigator Affiliation:

Peplin

Authority:

Australia: Human Research Ethics Committee

Study ID:

PEP005-013

NCT ID:

NCT00544258

Start Date:

October 2007

Completion Date:

May 2008

Related Keywords:

  • Actinic Keratoses
  • Pharmacokinetic study
  • Actinic Keratosis
  • Topical
  • Dermatology
  • Keratosis
  • Keratosis, Actinic

Name

Location